Paolo Prandoni Selected Research

Paolo Prandoni Research Topics

Disease

90	Venous Thromboembolism 05/2024 - 03/2002
57	Hemorrhage 04/2024 - 11/2002
47	Neoplasms (Cancer) 10/2022 - 06/2002
45	Venous Thrombosis (Deep-Vein Thrombosis) 02/2024 - 04/2002
34	Thrombosis (Thrombus) 06/2023 - 04/2002
29	Pulmonary Embolism 01/2023 - 07/2003
9	Thrombophilia 11/2022 - 12/2003
9	Thromboembolism 01/2022 - 06/2002
8	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2003
7	COVID-19 01/2023 - 01/2020
6	Atrial Fibrillation 01/2022 - 05/2008
5	Obesity 01/2017 - 08/2006
5	Stroke (Strokes) 08/2016 - 10/2011
4	Myocardial Infarction 10/2022 - 09/2014
4	Critical Illness (Critically Ill) 12/2020 - 12/2005
4	Body Weight (Weight, Body) 10/2018 - 05/2004
3	Postthrombotic Syndrome 02/2012 - 10/2006
2	Hypertension (High Blood Pressure) 01/2022 - 08/2006
2	Infections 01/2021 - 05/2016
2	Wounds and Injuries (Trauma) 10/2020 - 10/2002
2	Coronary Disease (Coronary Heart Disease) 08/2016 - 03/2015
2	Embolism (Embolus) 03/2015 - 01/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 06/2007
2	Right Ventricular Dysfunction 09/2014 - 11/2006
2	Hypotension (Low Blood Pressure) 02/2012 - 04/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2010 - 01/2005
2	Neoplasm Metastasis (Metastasis) 12/2010 - 09/2008
1	hereditary Thrombophilia 11/2022
1	Embolic Stroke 10/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2022
1	Overweight 12/2021
1	Menorrhagia 02/2021
1	Anemia 01/2021
1	Retinal Vein Occlusion 11/2018
1	Frailty 10/2018
1	Pulmonary Hypertension 01/2018
1	Venous Insufficiency 01/2018
1	Bursitis (Adhesive Capsulitis) 10/2017

Drug/Important Bio-Agent (IBA)

86	AnticoagulantsIBA 05/2024 - 06/2002
24	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2024 - 05/2004
21	RivaroxabanIBA 11/2022 - 10/2011
20	Vitamin K FDA Link 10/2022 - 05/2008
18	fibrin fragment D (D-dimer)IBA 04/2024 - 04/2002
16	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 05/2002
11	Warfarin (Coumadin)FDA LinkGeneric 02/2024 - 12/2003
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2021 - 02/2012
8	Fondaparinux (Arixtra)FDA Link 06/2023 - 09/2010
7	AntithrombinsIBA 11/2022 - 10/2002
7	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 01/2014
7	Prothrombin (Factor II)IBA 12/2015 - 10/2002
6	factor V LeidenIBA 04/2013 - 03/2002
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2011 - 02/2005
4	apixabanIBA 04/2024 - 03/2012
4	Dabigatran FDA Link 10/2016 - 04/2010
4	AntibodiesIBA 12/2009 - 04/2003
3	Protein CIBA 11/2020 - 10/2002
3	Blood Group Antigens (Blood Groups)IBA 01/2017 - 04/2013
3	bemiparinIBA 12/2010 - 06/2006
3	Antiphospholipid AntibodiesIBA 12/2009 - 02/2004
3	Hormones (Hormone)IBA 01/2007 - 06/2005
2	CreatinineIBA 10/2021 - 09/2008
2	Thrombin FDA Link 10/2016 - 10/2006
2	von Willebrand FactorIBA 01/2016 - 06/2007
2	Factor Xa InhibitorsIBA 09/2014 - 03/2012
2	Oral ContraceptivesIBA 08/2012 - 10/2002
2	Immunoglobulin G (IgG)IBA 12/2009 - 11/2005
2	Nadroparin (Nadroparin Calcium)IBA 04/2005 - 05/2004
2	SolutionsIBA 02/2005 - 09/2003
2	Factor V (Coagulation Factor V)IBA 01/2005 - 12/2003
2	ximelagatran (Exanta)IBA 07/2004 - 07/2004
1	insulin receptor-related receptor (IRR)IBA 04/2024
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	GlycosaminoglycansIBA 03/2021
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 03/2021
1	edoxabanIBA 01/2021
1	Protein SIBA 11/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2018
1	Cytochrome P-450 CYP3AIBA 10/2018
1	N(4)-oleylcytosine arabinosideIBA 06/2017
1	boldenone undecylenate (Equipoise)IBA 01/2017

Therapy/Procedure

59	Therapeutics 05/2024 - 11/2002
8	Compression Stockings 01/2022 - 08/2004
8	Drug Therapy (Chemotherapy) 11/2021 - 06/2002
5	Duration of Therapy 07/2022 - 07/2003
4	Secondary Prevention 11/2022 - 02/2005
4	Length of Stay 07/2022 - 09/2002
3	Contraindications 01/2021 - 04/2011
3	Central Venous Catheters 08/2019 - 10/2006
3	Catheters 01/2017 - 06/2008
2	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2022 - 07/2004
2	Aftercare (After-Treatment) 12/2018 - 12/2007
2	Subcutaneous Injections 01/2015 - 05/2002
1	Renal Dialysis (Hemodialysis) 10/2022
1	Vascular Surgical Procedures 01/2021
1	Drug Tapering 01/2021
1	Endarterectomy (Thromboendarterectomy) 01/2018
1	Orthopedic Procedures 12/2017
1	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2017